Rajasekhar Pradeep, Poole Daniel P, Veldhuis Nicholas A
Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, Parkville, VIC, Australia.
Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology, Parkville, VIC, Australia; The University of Melbourne, Parkville, VIC, Australia.
Adv Pharmacol. 2017;79:117-139. doi: 10.1016/bs.apha.2017.03.002. Epub 2017 Apr 24.
Transient receptor potential (TRP) ion channels are important signaling components in nociceptive and inflammatory pathways. This is attributed to their ability to function as polymodal sensors of environmental stimuli (chemical and mechanical) and as effector molecules in receptor signaling pathways. TRP vanilloid 4 (TRPV4) is a nonselective cation channel that is activated by multiple endogenous stimuli including shear stress, membrane stretch, and arachidonic acid metabolites. TRPV4 contributes to many important physiological processes and dysregulation of its activity is associated with chronic conditions of metabolism, inflammation, peripheral neuropathies, musculoskeletal development, and cardiovascular regulation. Mechanosensory and receptor- or lipid-mediated signaling functions of TRPV4 have historically been attributed to central and peripheral neurons. However, with the development of potent and selective pharmacological tools, transgenic mice and improved molecular and imaging techniques, many new roles for TRPV4 have been revealed in nonneuronal cells. In this chapter, we discuss these recent findings and highlight the need for greater characterization of TRPV4-mediated signaling in nonneuronal cell types that are either directly associated with neurons or indirectly control their excitability through release of sensitizing cellular factors. We address the integral role of these cells in sensory and inflammatory processes as well as their importance when considering undesirable on-target effects that may be caused by systemic delivery of TRPV4-selective pharmaceutical agents for treatment of chronic diseases. In future, this will drive a need for targeted drug delivery strategies to regulate such a diverse and promiscuous protein.
瞬时受体电位(TRP)离子通道是伤害性和炎症信号通路中的重要信号成分。这归因于它们能够作为环境刺激(化学和机械刺激)的多模式传感器以及受体信号通路中的效应分子发挥作用。TRP香草酸受体4(TRPV4)是一种非选择性阳离子通道,可被多种内源性刺激激活,包括剪切应力、膜拉伸和花生四烯酸代谢产物。TRPV4参与许多重要的生理过程,其活性失调与代谢、炎症、周围神经病变、肌肉骨骼发育和心血管调节等慢性疾病相关。TRPV4的机械感觉以及受体或脂质介导的信号功能以往一直被认为与中枢和外周神经元有关。然而,随着强效和选择性药理学工具、转基因小鼠以及改进的分子和成像技术的发展,TRPV4在非神经元细胞中的许多新作用被揭示出来。在本章中,我们将讨论这些最新发现,并强调需要更深入地了解TRPV4介导的信号在非神经元细胞类型中的特征,这些细胞类型要么与神经元直接相关,要么通过释放致敏细胞因子间接控制其兴奋性。我们将探讨这些细胞在感觉和炎症过程中的整体作用,以及在考虑TRPV4选择性药物全身给药治疗慢性疾病可能引起的不良靶标效应时它们的重要性。未来,这将推动对靶向药物递送策略的需求,以调控这样一种多样且作用广泛的蛋白质。